Skip to content
NACE Rev. 2.1 21.20 Active Rev. 2.1 21.2 ↗
● Official Registry Data: 2026-11-19

21.20 — Manufacture of pharmaceutical preparations

NACE Rev. 2.1 21.20 (Manufacture of pharmaceutical preparations) classifies within economic division 21 (Governed by Directive 2001/83/EC, EMA/National Marketing Authorization, EU GMP Annex 1, and Falsified Medicines serialization), linking EU/UN activity boundaries with US NAICS, UK SIC, and national regulatory obligations.

01 / Standard & Revision
NACE Rev. 2.1

Eurostat • v2.1

02 / Parent Hierarchy
21.2

Manufacture of pharmaceutical preparations

03 / Mapped Standards
12

NAICS 325199 • SIC 21200

04 / Subclasses & Scope
4 TR Subclasses

MCC 5122

Active Rev. 2.1Supersedes NACE Rev. 2:
01 / OFFICIAL SCOPE & OPERATORS

Activity Scope, Operators & Exclusions

Who Uses This Code & Typical Business Models

  • Active pharmaceutical ingredient (API) and finished drug makers
  • Vaccine, biologic, serum, and diagnostic preparation labs
  • Veterinary medicine and medicated surgical dressing manufacturers

This Class Includes

5
  • manufacture of medicaments: antisera and other blood fractions ; vaccines ; diverse medicaments, including homeopathic preparations
  • manufacture of chemical contraceptive products for external use and hormonal contraceptive medicaments
  • manufacture of medical diagnostic preparations, including pregnancy tests
  • manufacture of radioactive in-vivo diagnostic substances
  • manufacture of cell and gene advanced therapy medical products

Also Includes

  • manufacture of medical impregnated wadding, gauze, bandages, dressings, etc.
  • preparation of botanical products (grinding, grading, milling) for pharmaceutical use
  • manufacture of viral vector-based medicines or vaccines
  • manufacture of pharmaceutical preparations for veterinary medicines

This Class Excludes (Cross-References)

9
02 / REGULATORY & TAX DOSSIER

Legislation, Licensing, Incorporation & Tax Framework

Div. 21 • Sec. C Law 6948 Industrial Reg.

Governing Statutes & Regulations

Pharmaceutical Preparations Law No. 1262 EU-harmonized Pharmaceutical GMP Regulation Drug Marketing Authorization Reg. Industrial Registry Law No. 6948

Mandatory Permits, Licenses & Authorities

  • TİTCK Manufacturing Authorization, Good Manufacturing Practice (GMP) Certificate, and Drug Marketing Authorizations
  • İTS serialization integration & mandatory Qualified Person (Mesul Müdür)
  • Ministry of Agriculture Veterinary Drug License for 21.20 animal formulations

Incorporation Route & Chamber Registration

EU NACE Rev. 2.1 Framework
Governed by Directive 2001/83/EC, EMA/National Marketing Authorization, EU GMP Annex 1, and Falsified Medicines serialization.
United States (IRS / SBA / NAICS)
Maps to NAICS 3254. Requires FDA NDA/ANDA/BLA approval, strict 21 CFR 210/211 cGMP inspection, and DSCSA serialization.
United Kingdom (Companies House / HMRC)
Requires MHRA Manufacturer’s Licence (MIA), Marketing Authorisation, and Qualified Person batch release under UK SIC 21xxx.

VAT, Withholding & Statutory Incentives

  • Licensed pharmaceuticals carry 10% reduced VAT in Turkey.
  • Classified as High-Technology Manufacturing: qualifies for KOSGEB Business Dev grants, Law 5746 R&D Center deductions, and Priority/Strategic Investment Incentives.

Cross-Border Regulatory Frameworks (EU / US / UK)

TR • Corporate & Tradesmen Registry

Chamber of Industry / Commerce + Industrial Registry (Capital Company required) — JSC/LLC structure mandatory for GMP pharmaceutical manufacturing.

EU / Global Technical Alignment

Governed by Directive 2001/83/EC, EMA/National Marketing Authorization, EU GMP Annex 1, and Falsified Medicines serialization.

AUDIT & BOUNDARY CHECK

Classification Boundaries & Audit Risks

  • Dietary supplements and vitamins belong in Div. 10 (10.89) under Food Law, not Div. 21 drugs.
  • Non-medicated medical devices and surgical instruments sit in Div. 32 (32.50).
03 / NATIONAL COMPLIANCE

Turkish 6-Digit NACE Subclasses & OHS Hazard Classes

44Medium
04 / INTERNATIONAL CROSSWALK & MCC

Global Classification Passport

Verified structural and concordance mappings across EU, US, UK, UN, and national registries.

Payment Processing & ISO 18245 MCC Profile

Visa / Mastercard ISO 18245
MCC 5122
High Risk / Reserve Review
Drugs, Drug Proprietaries and Druggists Sundries

Strictly underwritten: non-OTC pharmaceuticals require pharmacy licensing and Card Brand high-risk registration.

05 / BOUNDARIES & COMPARISON

Critical Distinctions & Sibling Codes

Open Full Comparison Tool →
06 / TAXONOMY TREE

Classification Hierarchy & Data Export

07 / FAQ

Frequently Asked Questions

What business activities and models fall under NACE Rev. 2.1 21.20?

21.20 (Manufacture of pharmaceutical preparations): manufacture of medicaments: antisera and other blood fractions ; vaccines ; diverse medicaments, including homeopathic preparations; manufacture of chemical contraceptive products for external use and hormonal contraceptive medicaments; manufacture of medical diagnostic preparations, including pregnancy tests. Typical operators: Active pharmaceutical ingredient (API) and finished drug makers; Vaccine, biologic, serum, and diagnostic preparation labs.

What regulatory licensing and tax rules apply to 21.20 across EU, US, UK, or Turkey?

EU: Governed by Directive 2001/83/EC, EMA/National Marketing Authorization, EU GMP Annex 1, and Falsified Medicines serialization. US: Maps to NAICS 3254. Requires FDA NDA/ANDA/BLA approval, strict 21 CFR 210/211 cGMP inspection, and DSCSA serialization. UK: Requires MHRA Manufacturer’s Licence (MIA), Marketing Authorisation, and Qualified Person batch release under UK SIC 21xxx.

What are the international classification equivalents and MCC code for 21.20?

Verified concordance for 21.20: US NAICS 2022: 325199 (All Other Basic Organic Chemical Manufacturing), 325411 (Medicinal and Botanical Manufacturing), 325412 (Pharmaceutical Preparation Manufacturing) • UK SIC 2007: 21200 (Manufacture of pharmaceutical preparations) • Payment MCC 5122 (Drugs, Drug Proprietaries and Druggists Sundries).

What was 21.20 under legacy NACE Rev. 2?

Under official Eurostat concordance, NACE Rev. 2.1 21.20 corresponds to NACE Rev. 2 21.20 (Manufacture of pharmaceutical preparations).

Which activities are excluded from NACE Rev. 2.1 21.20?

Official explanatory notes exclude: manufacture of herb infusions (mint, vervain, chamomile, etc.), see 10.83; manufacture of probiotics, see 21.10; manufacture of dental cement and other dental fillings, see 32.50.